InvestorsHub Logo
Followers 0
Posts 383
Boards Moderated 1
Alias Born 07/28/2023

Re: Howzitgoing post# 64332

Thursday, 05/16/2024 1:35:03 PM

Thursday, May 16, 2024 1:35:03 PM

Post# of 65418
🤣 Oh that is all you have? I thought there might be something more reliable you were basing your claims on.

That paragraph from the press release (issued by a company that has lied in previous press releases or at the very least incompetently provided false information in press releases) reads:

"Therapeutic Solutions International owns a Phase III Investigational New Drug application for treatment of COVID-19. However, the Company is working on a new application for treating “all-cause” acute respiratory distress syndrome (ARDS) using the company’s patented JadiCell1, a true mesenchymal stem cell. Additionally, the Company has filed a Phase I/II clinical trial for COPD and possesses preclinical data for pulmonary fibrosis. All of these conditions are examples of lung inflammation."

We know that TSOI does not own that IND. It defaulted on the 1.8 Million that was due in 3.23. We also know that the new application re: ARDS was filed over a year ago and was likely not approved. Why would FDA approve it when TSOI does not have a completed P2? 🤣🤣🤣 Given all of that BS why would anyone think the PI/II application is true?

We will see where that is at in 30 days. That one is the only one that actually seems to have a chance. TSOI will be starting by trying to complete a registered P1 for a change, if and when it gets the opportunity and funding to actually do so There is no P3 unless you believe crazy stories make it real.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TSOI News